7-159028278-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_003382.5(VIPR2):​c.*2338G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.438 in 154,596 control chromosomes in the GnomAD database, including 17,195 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.44 ( 16852 hom., cov: 35)
Exomes 𝑓: 0.51 ( 343 hom. )

Consequence

VIPR2
NM_003382.5 3_prime_UTR

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.00700

Publications

17 publications found
Variant links:
Genes affected
VIPR2 (HGNC:12695): (vasoactive intestinal peptide receptor 2) This gene encodes a receptor for vasoactive intestinal peptide, a small neuropeptide. Vasoactive intestinal peptide is involved in smooth muscle relaxation, exocrine and endocrine secretion, and water and ion flux in lung and intestinal epithelia. Its actions are effected through integral membrane receptors associated with a guanine nucleotide binding protein which activates adenylate cyclase. [provided by RefSeq, Aug 2011]
LINC00689 (HGNC:27217): (long intergenic non-protein coding RNA 689)

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_003382.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.574 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_003382.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
VIPR2
NM_003382.5
MANE Select
c.*2338G>A
3_prime_UTR
Exon 13 of 13NP_003373.2
VIPR2
NM_001308259.1
c.*2338G>A
3_prime_UTR
Exon 10 of 10NP_001295188.1P41587-2
VIPR2
NM_001304522.2
c.*2338G>A
3_prime_UTR
Exon 11 of 11NP_001291451.1X5DP12

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
VIPR2
ENST00000262178.7
TSL:1 MANE Select
c.*2338G>A
3_prime_UTR
Exon 13 of 13ENSP00000262178.2P41587-1
LINC00689
ENST00000413238.2
TSL:1
n.4065C>T
non_coding_transcript_exon
Exon 6 of 6
VIPR2
ENST00000958129.1
c.*2338G>A
3_prime_UTR
Exon 11 of 11ENSP00000628188.1

Frequencies

GnomAD3 genomes
AF:
0.436
AC:
66372
AN:
152062
Hom.:
16838
Cov.:
35
show subpopulations
Gnomad AFR
AF:
0.186
Gnomad AMI
AF:
0.489
Gnomad AMR
AF:
0.497
Gnomad ASJ
AF:
0.575
Gnomad EAS
AF:
0.172
Gnomad SAS
AF:
0.429
Gnomad FIN
AF:
0.493
Gnomad MID
AF:
0.430
Gnomad NFE
AF:
0.579
Gnomad OTH
AF:
0.464
GnomAD4 exome
AF:
0.510
AC:
1231
AN:
2416
Hom.:
343
Cov.:
0
AF XY:
0.511
AC XY:
639
AN XY:
1250
show subpopulations
African (AFR)
AF:
0.150
AC:
9
AN:
60
American (AMR)
AF:
0.587
AC:
27
AN:
46
Ashkenazi Jewish (ASJ)
AF:
0.518
AC:
29
AN:
56
East Asian (EAS)
AF:
0.174
AC:
39
AN:
224
South Asian (SAS)
AF:
0.467
AC:
14
AN:
30
European-Finnish (FIN)
AF:
0.492
AC:
195
AN:
396
Middle Eastern (MID)
AF:
0.455
AC:
10
AN:
22
European-Non Finnish (NFE)
AF:
0.581
AC:
839
AN:
1444
Other (OTH)
AF:
0.500
AC:
69
AN:
138
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.513
Heterozygous variant carriers
0
25
51
76
102
127
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.436
AC:
66411
AN:
152180
Hom.:
16852
Cov.:
35
AF XY:
0.429
AC XY:
31880
AN XY:
74392
show subpopulations
African (AFR)
AF:
0.186
AC:
7709
AN:
41538
American (AMR)
AF:
0.498
AC:
7617
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.575
AC:
1996
AN:
3472
East Asian (EAS)
AF:
0.172
AC:
892
AN:
5172
South Asian (SAS)
AF:
0.429
AC:
2070
AN:
4824
European-Finnish (FIN)
AF:
0.493
AC:
5218
AN:
10582
Middle Eastern (MID)
AF:
0.435
AC:
128
AN:
294
European-Non Finnish (NFE)
AF:
0.579
AC:
39354
AN:
67968
Other (OTH)
AF:
0.465
AC:
982
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1746
3492
5239
6985
8731
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
604
1208
1812
2416
3020
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.519
Hom.:
31442
Bravo
AF:
0.429
Asia WGS
AF:
0.296
AC:
1035
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
2.5
DANN
Benign
0.70
PhyloP100
-0.0070
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs885863;
hg19: chr7-158820969;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.